Cytidine is a nucleoside molecule formed when cytosine is attached to a ribose ring (also known as a ribofuranose) via a ?-N1-glycosidic bond. Cytidine is a component of RNA.The transport of cytidine into the brain's extracellular fluid and then into neurons and glia are essential prerequisites for cytidine to be utilized in the brain.Cytidine deamination of nucleic acids underlies the diversification of Ig genes and inhibition of retroviral infection, and thus, it would appear to be vital to host defense. Activation-induced cytidinedeaminase (AID) induces the diversification of antibodies by deaminatingdeoxycytidine (C) within immunoglobulin genes. It initiates DNA lesions at immunoglobulin (Ig) loci that mediate antibody diversification. Inherited defects in AID result in hyper IgM immunodeficiency. AID also acts genome-wide, leading to cancer-driving mutations and chromosomal translocations
MARKET DYNAMICS
The cytidine market has shown a significant evolution over the forecast period. The key driving factors include the increasing research and development in pharmaceutical, biotechnology and molecular science, and genomics.Activation-induced cytidinedeaminase (AID) is known for its established role in antibody production. The increasing incidences of viral infections such as HIV (Human Immunodeficiency Virus), Human T-Cell Lymphotropic Virus (HTLV), Hepatitis B Virus (HBV), Human Herpesviruses (HHV), and many others are fuelling the market growth. Moreover, it is estimated that 2 billion people have been infected, and more than 240 million have chronic liver infections worldwide. Hepatitis B Virusinfection can cause acute and chronic liver disease, including cirrhosis and hepatocellular carcinoma. Technological advances and multiple upcoming pieces of researchare boosting the market growth. However, a high-cost investment in research and development is likely to hamper the market growth. Also, uncontrolled cytidine deamination might generate misfolded polypeptides, dominant-negative proteins, or mutations in tumor suppressor genes, and thus contribute to tumor formation, thereby restraining the cytidine market.
MARKET SCOPE
The "Cytidine Market Analysis to 2028" is a specialized and in-depth study of biotechnology in the healthcare industry, focusing on the global market trend analysis. This reportoutlines the cytidine marketwith detailed market segmentation by type, application, and end-user. The cytidine marketis expected to witness a high rise during the forecast period. The report focuses on the vital statistics on the market status of the leading players in the cytidine marketand offers key trends and opportunities.
MARKET SEGMENTATION
The market is segmented based on type, application, and end-user. Based on type, the market is categorized as cytarabine and azacitidine.Based onthe application, the market is segmented as cancer therapy and acute leukemia therapy. Based on the end-user, the market is segmented ashospitals, clinics, and others.
REGIONAL FRAMEWORK
The report lays out a comprehensive outline of the industry, including both quantitative and qualitative information. The report gives a sketch and forecast of the cytidine marketbased onvarious segments.It also consistsof market size and forecast estimates from the year 2020 to2028 concerning five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The marketby each region is then subdivided into respective countries and segments. The report comprises the analysis and forecast of eighteen countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the cytidine marketfrom both the demand and supply side. Moreover, it evaluates market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends.
The report also consistsof precise PEST analysis for all five regions, namely; North America, Europe, APAC, MEA, and South & Central America, after evaluating political, economic, social, and technological factors affecting the cytidine marketin these regions.
MARKET PLAYERS
The report contains critical developments in the cytidine marketas organic and inorganic growth strategies. Various enterprisesfocuson organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed in the market were acquisitions and partnerships & collaborations. These activities have paved the way for the expansion of business and customer base of market players. The market players from the cytidine marketare anticipated to have profitable growth opportunities in the coming years with the rising demand for the cytidine market globally. Given below is the list of few companies engaged in the cytidine market.
The report also consists of the profiles of key players in the cytidine market, along with their SWOT analysis and market strategies. Additionally, the report elaborates on leading industry players with information on company profiles, components, and services provided, financial information of the last three years, critical development in the past five years.
- HBio (Hellenic Bio Cluster)
- Pfizer Inc.
- Amgen Inc.
- F. Hoffmann-La Roche Ltd
- BIOGEN IDEC INC.
- Cipla
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- Sigma-Aldrich, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and provides various customization options in the current study.